Interestingly, we observed several significantly dysregulated key genes involved in cellular processes and cancer treatment, including cell cycle (GADD45A and GADD45B in Figure 8D), apoptosis (BCL2L1 and CFLAR in Figure 8E), stem-cell renewal and drug resistance (SOX2 and ABCB1 in Figure 8F), and immunotherapy (MICA and ULBP1 in Figure 8G). This evidence concerns the gene GADD45A and cancer.